Are you feeling seasick? Sail through calmer waters with these lower volatility investments. These handpicked stocks were carefully selected by our analysts for their history of stability and potential for consistent returns over time.
These companies have demonstrated resilience during previous market downturns, potentially offering protection when markets get rough. Their stability could help you sleep better at night.
Research suggests low-volatility stocks can deliver competitive returns with less dramatic ups and downs. You might enjoy similar growth potential without the rollercoaster ride.
From healthcare to consumer goods, these established companies are household names with proven business models. Their market dominance provides a competitive advantage that's hard to shake.
Low-volatility stocks have historically outperformed their high-volatility counterparts over the long term. These investments provide a smoother journey through market turbulence while still offering competitive returns, making them ideal anchors for a well-balanced portfolio.
These companies tend to be established industry leaders with strong balance sheets and consistent earnings. While they may not deliver dramatic growth spurts, they typically offer a favorable risk-to-reward profile and can provide greater peace of mind during market downturns.
Each company in this collection was selected for its established market position, financial stability, and track record of weathering economic storms. These stocks represent diverse sectors but share common qualities: reliability, strong fundamentals, and lower sensitivity to market swings.
Summary data for the 'Low Volatility Stocks' basket including total market capitalisation and breakdown by constituent market caps.
JNJ: $462.30B
XOM: $480.51B
UNH: $330.91B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+2.22%
On average, analysts expect assets in this group to grow 2.22% over the next year.
7 of 7 assets in this group are rated Buy by professional analysts.
